The Genome Analysis Centre (TGAC) in Norwich, England has been using a nanopore-sensing technology called the MinION, a product introduced by Oxford Nanopore Technologies Ltd, a U.K.-based startup company. The research team plans toShow More Summary
The following article is satire. In the first application of a new “reverse AMA” system put into place to improve patient satisfaction, a patient was admitted to the hospital for the first time against the wishes of her treating ED physician. Constance Dolor, a 37-year-old morbidly obese patient with chronic unexplained pain and a frequent […]
It came out of nowhere. One of those life lessons that I didn’t know I needed to learn. Until I did. There I was, at a weekend business retreat, hobnobbing with a group of women executives. Feeling only slightly out of my element. Trying to blend in. There was a break in the meeting. And […]
Amidoc wrote this comment: Thank you for sharing this with us. How about focus on teaching how to avoid clinical errors during medical school and residency? I am sure someone smart can come up with a curriculum and the apply it in real life. Yesterday I gave Grand Rounds at my alma mater – the […]
Behind every doctor is a little boy or girl who once watched helplessly. Maybe it was her father or grandfather who suffered under the weight of a disease that was deemed all but incurable. Perhaps her own skin was battered and bruised by the repeated trauma of an unrelenting tourniquet. She swore that when (if) […]
In a new report, the World Health Organization is urging European countries to share information about the cost-effectiveness of drugs, and also consider off-label use of medicines, as a way to combat budgetary pressures from rising drug prices.
More states are passing 'right to try' laws to widen access to experimental medicines for people facing life-threatening illnesses, but experts say the laws do not accomplish the goal, while advocates say the laws may spur Congress to act.
The latest comings and goings in the pharmaceutical industry.
And so, yet another working week will soon draw to a close. Not a moment too soon, yes? After all, it has been a rather busy week. Now, though, we get to dream about weekend plans. Once again, the agenda is fairly modest. We expect to catch up on some reading, take a nap or three and possibly check in on the Pharmalot ancestors. Show More Summary
MIT's Bob Langer has another idea: he's looking to change the way that entire courses of treatment are dosed. What if an extended-release formulation, for an oral drug, was really extended release. Days, weeks? Instead of taking pills...Show More Summary
It was like magic, a vote was held in the House of Representatives on the Medicare "Doc Fix" and moments later, my inbox was filled with press releases from the American College of Cardiology and the AMA. A few seconds later, a somewhat...Show More Summary
From a recent study: Methods and Results In a randomized, 2?period (6 week/period), crossover, controlled?feeding study of 48 individuals with elevated LDL?C (149±3 mg/dL), a cholesterol?lowering diet with almonds (1.5 oz. of almonds/day) was compared to an identical diet with an isocaloric muffin substitution (no almonds/day). Show More Summary
The other day some cardiologists on Twitter were discussing whether a patient should be blamed if a permanent pacemaker lead became displaced. The consensus seemed to be that it was probably poor placement (i.e., operator error), rather than patient behavior that caused leads to dislodge. Continue reading... Your patients are rating you online: How […]
On Thursday at the Health Innovation Summit at New Orleans Entrepreneur Week (NOEW), Ochsner Health System announced the launch of an innovation accelerator called iO designed to support and partner with companies working to revolutionize patient-centered care, NOLA first reports. Show More Summary
This appeared a little while ago.EHRs: Expecting Too Much, Too Soon?by Peter Kilbridge and Doug Thompson In 2014, health care record-keeping and communication are finally emerging from the Stone Age and entering the 21st century, moving...Show More Summary
On Tuesday, the U.S. Patent & Trademark Office granted Google a patent for a smart contact lens that can monitor a wearer’s blood sugar levels. Last year, Google teamed up with European drug maker Novartis to develop a smart contact lens prototype that uses miniature sensors and a micro-thin radio antenna to track glucose levels that... Read More
Global revenues from connected fitness trackers is expected to increase from over $2 billion in 2014 to $5.4 billion by 2019, according to new report from market research firm Parks Associates. The report, Digitally Fit: Products and...Show More Summary
At the upcoming HIMSS conference in Chicago, Vital Connect (Campbell, CA), maker of the chest-worn HealthPatch MD vital signs monitor, will be showing off their tiny new chip for integrating data coming from a variety of biosensors.Show More Summary
Where does doctor stop and computer begin? Who is in charge? Do we care? Are these silly, academic questions from some sci-fi future or is it an onrushing tomorrow? Consider: Ten years ago, the EMR recorded the date you or your nurse gave Sam his flu shot. Today, the EMR reminds you it is time to have your nurse […]
This article in CCJM reviews the evidence, with a focus on the transcutaneous devices. The evidence from clinical trials is somewhat mixed and preliminary. As with any device, improvements in the technology far outpace clinical trials. The bottom line for now is that it is an emerging option for certain patients unable to take oral anticoagulants.